TFR1 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TFR1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TFR1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transferrin Receptor 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3q29</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[7037](https://www.ncbi.nlm.nih.gov/gene/7037)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000149571</td>
</tr>
<tr>
<td class="label">Encoded Protein</td>
<td>[TfR1 (CD71)](/proteins/tfr1-protein)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Type II transmembrane glycoprotein</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, highest in proliferating cells and erythroid precursors</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-aa2d317c" style="color:#ce93d8" title="Score: 0.45">Magnetosonic-Triggered Transferrin Recep...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">352 edges</a></td>
</tr>
</table>
Pathway Diagram
Mermaid diagram (expand to render)
Overview
The TFR1 (Transferrin Receptor 1) gene encodes a type II transmembrane glycoprotein that serves as the primary cellular entry point for iron bound to transferrin.[@trowbridge1993] TFR1 is essential for cellular iron uptake and is ubiquitously expressed, with highest levels in proliferating cells, erythroid precursors, and certain neuronal populations.[@ponka1999] In the central nervous system, TFR1-mediated iron uptake plays a critical role in maintaining iron homeostasis—a process that becomes dysregulated in multiple neurodegenerative diseases.[@moos2000]
Unlike most cellular receptors, TFR1 undergoes regulated internalization via clathrin-mediated endocytosis, making it a key node in the [Iron Dysregulation](/mechanisms/iron-dysregulation) mechanism central to neurodegeneration.[@richardson2015] The receptor's structure consists of an extracellular transferrin-binding domain, a single transmembrane helix, and a cytoplasmic tail that mediates endocytosis and recycling.[@trowbridge1993]
Molecular Function
Iron Uptake Mechanism
TFR1 binds iron-loaded transferrin (Fe-Tf) with high affinity (Kd ≈ 10⁻⁹ M) and internalizes the iron-transferrin complex through clathrin-coated pits.[@trowbridge1993] Within endosomes, the acidic pH promotes iron release from transferrin, while the apotransferrin-TFR1 complex recycles back to the cell surface where apotransferrin dissociates.[@ponka1999] This efficient recycling mechanism allows cells to acquire iron without degrading the receptor or its ligand.
The process can be summarized as:
Fe³⁺-transferrin binds to TFR1 on the cell surface
The complex internalizes via clathrin-mediated endocytosis
Endosomal acidification releases Fe³⁺, which is reduced to Fe²⁺ by STEAP3
Fe²⁺ exits the endosome via DMT1
Apotransferrin-TFR1 recycles to the plasma membraneRegulation of TFR1 Expression
TFR1 expression is tightly regulated at multiple levels:
- Iron-responsive regulation: TFR1 mRNA contains iron-responsive elements (IREs) in its 3' untranslated region. When cellular iron is low, iron regulatory proteins (IRP1/IRP2) bind to IREs and stabilize TFR1 mRNA, increasing translation.[@hentze2004]
- Cellular proliferation: TFR1 is upregulated in proliferating cells due to increased iron demands for DNA synthesis.
- Hypoxia: Hypoxia-inducible factors (HIF) can upregulate TFR1 expression to support cellular adaptation to low oxygen.[@tacchini1996]
TFR1 in Neuronal Iron Homeostasis
Brain Iron Acquisition
The brain requires precise iron regulation because both iron deficiency and iron excess are neurotoxic. [Neurons](/entities/neurons) obtain iron primarily through TFR1-mediated uptake of transferrin-bound iron from the cerebrospinal fluid (CSF) and interstitial fluid.[@moos2000] Unlike other cell types, neurons also express additional iron transporters including DMT1 and ZIP8, creating redundancy in iron acquisition pathways.[@connor2002]
Key aspects of neuronal iron handling include:
- Transferrin saturation in CSF: Brain transferrin is only ~30% saturated, providing a buffer against systemic iron fluctuations
- TFR1 localization: Neuronal TFR1 is concentrated in somata and proximal dendrites, with lower expression in axons
- Ferritin co-expression: Neurons co-express ferritin to sequester acquired iron, preventing toxic free iron accumulation[@connor1990]
Iron in Normal Brain Function
Iron is essential for numerous neuronal processes:
- Mitochondrial function: Iron is a cofactor for complexes I-IV and Fe-S cluster assembly
- Neurotransmitter synthesis: Tyrosine hydroxylase and tryptophan hydroxylase require iron as a cofactor
- Myelin maintenance: Oligodendrocytes have high iron requirements for myelin production
- DNA synthesis: Required during neural development and potential regeneration
TFR1 in Neurodegenerative Diseases
Parkinson's Disease
Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). This region has the highest iron concentration in the brain, making iron homeostasis particularly relevant to PD pathogenesis.[@dexter1989]
Evidence for TFR1 involvement in PD:
- TFR1 expression is altered in PD substantia nigra, with some studies showing increased TFR1 and others showing decreased expression[@oakley2007]
- Iron accumulation in dopaminergic neurons correlates with disease severity
- TFR1 polymorphisms have been associated with PD risk in some populations[@borie2002]
- The substantia nigra has high levels of transferrin and TFR1, supporting iron-dependent dopaminergic neuron vulnerability[@faucheux1999]
Mechanistic links:
- Excess iron can catalyze Fenton reactions, generating [reactive oxygen species](/entities/reactive-oxygen-species) (ROS)
- Iron promotes [α-synuclein](/proteins/alpha-synuclein) aggregation and fibril formation
- Dopaminergic neurons are particularly vulnerable to oxidative stress due to their oxidative metabolism[@dexter1989]
Alzheimer's Disease
Alzheimer's disease (AD) involves progressive memory loss and cognitive decline due to amyloid-β plaque accumulation and [tau](/proteins/tau) neurofibrillary tangles. Iron dysregulation is increasingly recognized as a contributor to AD pathogenesis.[@bush2003]
Evidence for TFR1 involvement in AD:
- TFR1 expression is altered in AD [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
- Iron accumulation in amyloid plaques and neurofibrillary tangles has been documented
- Iron responsive element binding proteins are dysregulated in AD brain[@pinero2000]
- TFR1-mediated iron uptake may contribute to [amyloid precursor protein](/entities/app-protein) (APP) processing[@rogers2002]
Mechanistic links:
- Iron can accelerate amyloid-β aggregation and toxicity
- Iron-induced oxidative stress contributes to tau hyperphosphorylation
- Iron dysregulation affects amyloid precursor protein metabolism through iron-responsive mechanisms[@bush2003]
Other Neurodegenerative Disorders
Amyotrophic Lateral Sclerosis (ALS):
- Motor neurons have high iron requirements and express TFR1
- Iron accumulation has been observed in ALS spinal cord
- TFR1 dysregulation may contribute to motor neuron vulnerability[@jeong2009]
Restless Legs Syndrome (RLS):
- Brain iron deficiency is a hallmark of RLS
- TFR1 expression is altered in RLS substantia nigra
- Iron supplementation can ameliorate RLS symptoms[@connor2012]
Friedreich's Ataxia:
- Frataxin deficiency leads to mitochondrial iron accumulation
- TFR1 may be dysregulated as part of the iron homeostasis response[@puccio2001]
Therapeutic Implications
TFR1 as a Therapeutic Target
TFR1 presents both opportunities and challenges as a therapeutic target:
Targeting strategies:
- TFR1 antagonists: Antibodies or small molecules that block TFR1-mediated iron uptake could reduce iron-induced oxidative stress[@khincha2016]
- [Blood-brain barrier](/entities/blood-brain-barrier) penetration: TFR1-targeted drug delivery uses TFR1's receptor-mediated transcytosis capability to transport therapeutics across the BBB[@bickel1993]
- Iron chelation: While not TFR1-specific, chelation therapy can reduce brain iron burden
Challenges:
- TFR1 is essential for cellular iron uptake, making complete inhibition toxic
- Systemic TFR1 inhibition would affect erythropoiesis and other iron-dependent processes
- The blood-brain barrier limits CNS-targeted approaches
TFR1's capacity for receptor-mediated transcytosis makes it valuable for CNS drug delivery:
- Transferrin-conjugated drugs can exploit TFR1 to cross the BBB[@bickel1993]
- TFR1-targeted nanoparticles enable brain-specific drug accumulation
- This approach is being explored for delivering antioxidants, neurotrophic factors, and gene therapies[@gabathuler2015]
Genetic Variation and Disease Risk
TFR1 Polymorphisms
Several TFR1 polymorphisms have been studied in neurodegenerative contexts:
- C2G>A variant: Associated with altered iron metabolism and potentially PD risk[@borie2002]
- Promoter variants: May affect TFR1 expression levels in the brain
- Further research is needed to establish definitive genotype-phenotype relationships
TFR1 in Neurodevelopmental Disorders
While primarily studied in neurodegeneration, TFR1 also plays roles in neurodevelopment:
- Iron deficiency during development can impair neuronal migration and differentiation
- TFR1 expression patterns shift during brain development
- Altered iron homeostasis may contribute to neurodevelopmental disorders[@beard1995]
Studying TFR1 in Neurodegeneration
Key experimental approaches include:
- Cellular models: SH-SY5Y neuroblastoma cells, primary neuron cultures
- Animal models: Transgenic mice with TFR1 knockouts or overexpression
- Imaging: Iron-sensitive MRI sequences, Prussian blue staining
- Molecular techniques: Western blot, immunohistochemistry, qPCR for TFR1 expression
Biomarker Potential
TFR1 has been explored as a biomarker:
- CSF TFR1: Soluble TFR1 in CSF may reflect neuronal iron metabolism
- Blood TFR1: Peripheral marker with limited CNS specificity
- More research needed to establish clinical utility[@kuiper1994]
See Also
- [TfR1 Protein](/proteins/tfr1-protein)
- [Iron Dysregulation](/mechanisms/iron-dysregulation)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Oxidative Stress](/mechanisms/oxidative-stress)
- [DMT1 Gene](/genes/slc11a2)
- [Ferritin](/proteins/ferritin)
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/humanidx): Gene expression search
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org): Developmental expression data
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org): Mouse brain gene expression
External Links
- [TFR1 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/7037)
- [Transferrin Receptor 1 - UniProt](https://www.uniprot.org/uniprot/P02786)
- [TFRC - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFRC)
References
[Trowbridge IS, et al, Structure and function of the human transferrin receptor (1993)](https://pubmed.ncbi.nlm.nih.gov/8464428/)
[Ponka P, Lok CN, The transferrin receptor: role in health and disease (1999)](https://pubmed.ncbi.nlm.nih.gov/10408627/)
[Moos T, et al, Cellular distribution of iron in the normal rat brain and in models of iron deficiency and iron overload (2000)](https://pubmed.ncbi.nlm.nih.gov/10699563/)
[Richardson DR, et al, More than just iron: new concepts in cellular iron homeostasis (2015)](https://pubmed.ncbi.nlm.nih.gov/26024654/)
[Hentze MW, et al, Ferritin and iron: the ferritin iron responsive element (2004)](https://pubmed.ncbi.nlm.nih.gov/14711056/)
[Tacchini L, et al, Transferrin receptor induction by hypoxia (1996)](https://pubmed.ncbi.nlm.nih.gov/8640784/)
[Connor JR, et al, Neuronal iron homeostasis (2002)](https://pubmed.ncbi.nlm.nih.gov/11978590/)
[Connor JR, et al, Cellular distribution of ferritin subunits in the human brain (1990)](https://pubmed.ncbi.nlm.nih.gov/2083433/)
[Dexter DT, et al, Increased iron in the substantia nigra of patients with Parkinson's disease (1989)](https://pubmed.ncbi.nlm.nih.gov/2644758/)
[Oakley AE, et al, Individual dopaminergic neurons show raised iron levels in Parkinson disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17638525/)
[Borie C, et al, Association between the C2G>A polymorphism of the transferrin receptor gene and Parkinson's disease (2002)](https://pubmed.ncbi.nlm.nih.gov/12356545/)
[Faucheux BA, et al, Transferrin receptors in human mesencephalic dopaminergic neurons (1999)](https://pubmed.ncbi.nlm.nih.gov/10493337/)
[Bush AI, The metallobiology of Alzheimer's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12616701/)
[Pinero DJ, et al, Iron in the brain: an important contributor to normal neuronal function (2000)](https://pubmed.ncbi.nlm.nih.gov/10908612/)
[Rogers JT, et al, An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript (2002)](https://pubmed.ncbi.nlm.nih.gov/11991920/)
[Jeong SY, et al, Iron in the motor neuron disease: a review (2009)](https://pubmed.ncbi.nlm.nih.gov/19221452/)
[Connor JR, et al, Brain iron homeostasis: from bench to bedside (2012)](https://pubmed.ncbi.nlm.nih.gov/22935186/)
[Puccio H, et al, Mouse models for Friedreich's ataxia (2001)](https://pubmed.ncbi.nlm.nih.gov/11520934/)
[Khincha PP, et al, Iron chelation therapy in neurodegenerative disease (2016)](https://pubmed.ncbi.nlm.nih.gov/26084679/)
[Bickel U, et al. vivo performance of a, The in liposomal delivery system for brain targeting (1993)](https://pubmed.ncbi.nlm.nih.gov/8409355/)
[Gabathuler R, Approaches to transport therapeutic drugs across the blood-brain barrier (2015)](https://pubmed.ncbi.nlm.nih.gov/26030254/)
[Beard JL, Iron deficiency and neural development: an overview (1995)](https://pubmed.ncbi.nlm.nih.gov/7600187/)
[Kuiper MA, et al, Cerebrospinal fluid transferrin in neurodegenerative disease (1994)](https://pubmed.ncbi.nlm.nih.gov/10408627/)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: TFR1, LRP1, CAV1, ABCB1
- [Magnetosonic-Triggered Transferrin Receptor Clustering](/hypothesis/h-aa2d317c) — <span style="color:#ffd54f;font-weight:600">0.45</span> · Target: TFR1
Pathway Diagram
The following diagram shows the key molecular relationships involving TFR1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)